Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Essential Healthcare News.
Press releases published on May 1, 2025
Omilia and SpinSci Technologies Join Forces to Revolutionize Patient Access with AI-Powered, EHR-Integrated Self-Service
EIN Presswire
·
May 1, 2025
DALLAS, TEXAS, TX, UNITED STATES, May 1, 2025 /EINPresswire.com/ -- Omilia, a global leader in Conversational AI (CAI), and SpinSci Technologies, a pioneer in cloud-based patient engagement, today announced a strategic partnership to transform patient …
Blue Evolution’s Dr. Charles Yarish to be Honored as North America’s 'Wizard of Seaweed' at ISS25
EIN Presswire
·
May 1, 2025
Pioneering seaweed scientist to be honored at International Seaweed Symposium; available for interviews on the future of regenerative seaweed innovation SAN JOSE, CA, UNITED STATES, May 1, 2025 /EINPresswire.com/ -- Blue Evolution, a leading innovator …
Jobma Unveils New AI Tools for Data-Driven Hiring, Including Resume Scoring and Smarter Tech Assessments
EIN Presswire
·
May 1, 2025
The new update introduces AI resume scoring and relevancy checks, smarter tech assessments, and stronger security for a seamless hiring experience. MINNETONKA, MN, UNITED STATES, May 1, 2025 /EINPresswire.com/ -- Jobma, a leading AI hiring platform, …
Louisiana Mesothelioma Victims Center Urges the Family of a Journeyman Plumber Who Now Has Mesothelioma or Lung Cancer in Louisiana to Call the Gori Law Firm-Expect Better Compensation Results
EIN Presswire
·
May 1, 2025
NEW ORLEANS, LA, UNITED STATES, May 1, 2025 /EINPresswire.com/ -- The Louisiana Mesothelioma Victims Center says, "We are urging the family of a former journeyman plumber who has just been diagnosed with mesothelioma or lung cancer in Louisiana to make …
Emergent BioSolutions Reinforces Commitment to Opioid Emergency Preparedness Efforts in Canada Through Multi-Year Contract with Ontario Ministry of Health
GlobeNewswire
·
May 1, 2025
WINNIPEG, Manitoba, May 01, 2025 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions Inc. (NYSE: EBS) announced a maximum three-year agreement with a value of approximately $65 million to supply the Ontario Ministry of Health with NARCAN® Nasal Spray for the …
Coherus to Participate in Upcoming Investor Conferences
GlobeNewswire
·
May 1, 2025
REDWOOD CITY, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus,” NASDAQ: CHRS) today announced that the company will be webcasting its participation in the upcoming conferences: Citizens Life Science Conference in New York, NY …
Infinity Rehab Partners with Tierra Rose Care Center
EIN Presswire
·
May 1, 2025
TUALATIN, OR, UNITED STATES, May 1, 2025 /EINPresswire.com/ -- Infinity Rehab, a therapy and rehab services company, is pleased to partner with and provide therapy services for Tierra Rose Senior Living Community as of April 14, 2025. Tierra Rose is …
Channel Therapeutics Provides Announcement on 2024 Annual Report to Comply with NYSE American Listing Rules
GlobeNewswire
·
May 1, 2025
FREEHOLD, N.J., May 01, 2025 (GLOBE NEWSWIRE) -- Channel Therapeutics Corporation, (“Channel” or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain treatment therapeutics, today advises that, as previously disclosed in …
Premier Health Announces Results of Shareholders’ Meeting
GlobeNewswire
·
May 1, 2025
MONTRÉAL, May 01, 2025 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA) (the “Corporation” or “Premier Health”), a leading Canadian Healthtech company, announces that all matters submitted to shareholders for approval were approved at its …
Precipio Announces Q1-2025 Shareholder Update Call
GlobeNewswire
·
May 1, 2025
NEW HAVEN, Conn., May 01, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q1-2025 corporate update call on May 15th, 2025 at 5:00 PM ET. The call will include updates on all of the company’s …
Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 1, 2025
SAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other tumor …
Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025
GlobeNewswire
·
May 1, 2025
DEER PARK, Ill., May 01, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will …
Primary Care Physician Use of Counterpart Assistant Technology Associated with Better Health Outcomes in Patients with Congestive Heart Failure
GlobeNewswire
·
May 1, 2025
WILMINGTON, Del., May 01, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) and a leading AI-powered physician- …
MacroGenics to Participate in Upcoming Investor Conference
GlobeNewswire
·
May 1, 2025
ROCKVILLE, MD, May 01, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative antibody-based therapeutics for the treatment of cancer, today …
Qualigen Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K
GlobeNewswire
·
May 1, 2025
CARLSBAD, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) announced today that it received an expected deficiency notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC …
Shattuck Labs Reports First Quarter 2025 Financial Results and Recent Business Highlights
GlobeNewswire
·
May 1, 2025
– Company advances SL-325 program with an IND filing expected in the third quarter of 2025 – – Cash balance of approximately $60.9 million as of March 31, 2025, expected to fund operations into 2027 – AUSTIN, TX and DURHAM, NC, May 01, 2025 (GLOBE NEWSWIRE …
Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 1, 2025
FLORHAM PARK, N.J., May 01, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced that, in …
New Owner of Costa Rica Recovery Aims to Make Drug Rehab Available to Costa Ricans and Travelers from North America
EIN Presswire
·
May 1, 2025
Scott Huseby’s journey from accomplished entrepreneur to compassionate recovery advocate came about after experiencing the healing power of recovery firsthand. SAN JOSé, COSTA RICA, May 1, 2025 /EINPresswire.com/ -- Scott Huseby is the new owner of …
Cytokinetics Announces New PDUFA Date for Aficamten in Obstructive Hypertrophic Cardiomyopathy
GlobeNewswire
·
May 1, 2025
SOUTH SAN FRANCISCO, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) action date for the New Drug …
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 1, 2025
CAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted eight newly-hired employees options to purchase an …